Toggle light / dark theme

The US just promised to adopt universal health care

Every single member of the UN doubled-down today on a commitment to provide universal health coverage to their citizens. The fact that the US will be among them is perhaps evidence of how disconnected these declarations can be from actual domestic political agendas.

Yet the issue is important, and it shows just how out of line the US approach to health care coverage is compared to the rest of the world. Only about half the world’s population has access to the kind of affordable health care services that don’t require crippling out-of-pocket costs. Most of those people are in mid- and low-income countries. Or they are in the wealthiest country on Earth: the US.

Bringing universal health care to everyone is one of the “sustainable development goals,” the ambitious to-do list for UN member countries to complete by 2030. For the UN, universal health care means, “financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.”

Dr Aubrey de Grey | Investing in the Age of Longevity 2019

Rejuvenation Biotechnology: on track to be the biggest industry ever.

Dr Aubrey de Grey, CSO at the SENS Research Foundation speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Aubrey discusses Rejuvenation biotechnology and how it’s on track to become the biggest industry ever.

Master Investor is an investment media and events company that delivers independent, financial commentary and analysis to UK private investors and traders through events, magazines, news, blogs, podcasts and daily/weekly newsletters.
Read our latest magazine at www.masterinvestor.co.uk/magazine
Book a free ticket (use code MIYT) to attend the annual Master Investor Show (28th March 2020): https://masterinvestorshow-2020.reg.buzz
Keep in touch:
Newsletter | https://masterinvestor.co.uk/subscribe
Twitter | https://twitter.com/masterinvestor
Facebook | https://facebook.com/masterinvestor
LinkedIn | https://www.linkedin.com/company/masterinvestor

Reason | Investing in the Age of Longevity 2019

Gene therapies to reverse immunosenescence and atherosclerosis.

CEO of Repair Biotechnologies speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Reason discusses gene therapies to reverse immunosenescence and atherosclerosis.

Master Investor is an investment media and events company that delivers independent, financial commentary and analysis to UK private investors and traders through events, magazines, news, blogs, podcasts and daily/weekly newsletters.

Read our latest magazine at www.masterinvestor.co.uk/magazine

Book a free ticket (use code MIYT) to attend the annual Master Investor Show (28th March 2020): https://masterinvestorshow-2020.reg.buzz

Keep in touch:

Singapore’s human-centric artificial intelligence strategy | The Straits Times

The national artificial intelligence strategy, which was unveiled in November, will focus on five key sectors — transport and logistics, smart cities and estates, safety and security, healthcare, and education.

Read the full story: https://www.straitstimes.com/singapore/tapping-ai-to-deliver…ect-issues

Get the latest news updates: http://www.straitstimes.com

Follow The Straits Times online:
Twitter: https://www.twitter.com/STcom
Facebook: https://www.facebook.com/TheStraitsTimes
Instagram: https://www.instagram.com/straits_times/

About The Straits Times:
The Straits Times, the English flagship daily of SPH, has been serving readers for more than a century. Launched on July 15, 1845, its comprehensive coverage of world news, East Asian news, Southeast Asian news, home news, sports news, financial news and lifestyle updates makes The Straits Times the most-read newspaper in Singapore.

How to Start at The Finish Line: Cancer Survivor

Hollie Fraser, founder of Books On The Move, worldwide book sharing movement, creative director and ideaXme literature, reading and writing ambassador interviews Matthew Newman, 2019 best Kindle book author.

Matthew S. Newman, is a 39 year old cancer survivor and best-selling author of Starting At The Finish Line. He is a fitness aficionado, and a financial services industry speaker. His mission is help the wider public and to encourage financial preparedness. He does this by telling his story of brain cancer survival and the financial lessons and wisdom he learnt as a result.

Matthew’s book was named a Best Kindle Unlimited Books for 2019. To this day, fitness is still a big part of his life. You can see him here working out shortly after brain surgery! https://www.youtube.com/watch?v=J2G-Sq7iOuM

He is a TedX Talk participant and currently traveling the country giving talks to financial services organizations, such as Transamerica, Primerica, Raymond James and more. https://matthewsnewman.com/speaking

For the text version of this interview please visit www.radioideaxme.com from week commencing 2 December 2019.

German robotics set to shrink for first time in decade

Germany’s prized industrial robotics and automation sector is expecting a drop in sales this year for the first time since the global financial crisis, an industry body said on Friday.

The Mechanical Engineering Industry Association (VDMA) is expecting sales to fall by five percent to 14.3 billion euros ($15.8 billion) this year.

This would be the first drop since the 32-percent plunge seen in 2009 in the wake of the crisis.

Brent Nally interviews Dr. Michael Fossel about Telocyte and telomerase gene therapy on 11/16/2019

Haven’t heard from Fossel in awhile. This is long but well indexed in the notes.


My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself.

This video me, Brent Nally, interviewing Dr. Michael Fossel about Telocyte and telomerase gene therapy on November 16, 2019.

- Please consider a donation to me: My PayPal https://paypal.me/BrentNally or my Bitcoin Cash (BCH) address: qr9gcfv92pzwfwa5hj9sqk3ptcnr5jss2g78n7w6f2

SHOW NOTES:

Landmark Longevity Summits at King’s College London

“Demonstrate That Top Financial and Tech Corporations Are Committed to Longevity”


This week two Landmark International Longevity Summits in London attracted the attention of scientists, government officials, major financial corporations, insurance companies, investment banks, and technology companies from around the world. The Landmark AI for Longevity Summit and the First International Longevity Policy and Governance Summit at King’s College London are expected to become the world-leading forums for the Longevity Industry.

Landmark Summits Reveal the Future of National Economies

Deep Knowledge Group is delighted to have supported and participated in the landmark International Longevity Policy and Governance and AI for Longevity Summits that took place on November 12th at King’s College London, which gathered an unprecedented density and diversity of speakers and panelists at the intersection of Longevity, AI, Policy and Finance. The summits were organized by Longevity International UK and the AI Longevity Consortium at King’s College London, with the strategic support of Deep Knowledge Group, Aging Analytics Agency, Ageing Research at King’s (ARK) and the Biogerontology Research Foundation. Together they managed to attract the interest of major financial corporations, insurance companies, investment banks, Pharma and Tech corporations, and representatives of international governmental bodies, organisations and embassies, as well as leading media, and featured presentations and panel discussions from top executives and directors of Prudential, Barclays Business UK, HSBC, AXA, L&G, Longevity. Capital, Longevity Vision Fund, Juvenescence, the UK Office of AI, Microsoft, NVIDIA, Babylon Health, Huawei Europe, Insilico Medicine, Longevity International UK, the Longevity AI Consortium and others.


November 14, 2019, London, UK: Deep Knowledge Group executives Dmitry Kaminksiy and Eric Kihlstrom spoke at a landmark one-day event held yesterday at King’s College London with the strategic support Deep Knowledge Group. The event united two Longevity-themed summits under the shared strategic agenda of enabling a paradigm shift from treatment to prevention and from prevention to Precision Health via the synergistic efforts of science, industry, AI, policy and governance, to enable the UK to become an international leader in Healthy Longevity.

Goldman Sachs has created a market-ready robo advisor

If Goldman Sachs’ new tool launches through Marcus, a human-digital hybrid approach would be a wise choice.


Goldman Sachs created a market-ready robo advisor and is mulling how to launch it, Financial Planning reports. The automated platform will represent Goldman’s digital entry into the smaller investor market, per Rachel Schnoll — who recently became the head of Goldman’s FinLife CX RIA platform — as cited by Financial Planning. The new robo advisor may be built in part on algorithms that Goldman acquired from financial life management firm United Capital, when it acquired the company for $750 million in May.

The new robo advisor could be introduced to the market via Goldman’s Marcus segment — here’s why it would be a good match. Goldman could extend a portion of the personal touch it brings to its Private Wealth Management clients to Marcus clients by offering them financial advice via the new robo advisor.

This could help elevate the bank’s play to target more retail banking customers, and could make up for the fact that the high interest rate Marcus boasts slipped from 2.25% to 1.9% since July. But Marcus isn’t the only potential route to market: Goldman is also considering launching its robo tech to financial advisors on the United Capital platform, per Schnoll.